These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 27863037)

  • 21. Targeted delivery of chemotherapy agents using a liver cancer-specific aptamer.
    Meng L; Yang L; Zhao X; Zhang L; Zhu H; Liu C; Tan W
    PLoS One; 2012; 7(4):e33434. PubMed ID: 22558072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Reversing multidrug resistance in breast cancer cell line MCF-7/ADR by small interfering RNA].
    Li CB; Zhang F; Shi YR; Wei XY; Yang Y; Niu RF
    Ai Zheng; 2004 Dec; 23(12):1605-10. PubMed ID: 15601546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
    Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
    Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Delivery of siRNA by MRI-visible nanovehicles to overcome drug resistance in MCF-7/ADR human breast cancer cells.
    Lin G; Zhu W; Yang L; Wu J; Lin B; Xu Y; Cheng Z; Xia C; Gong Q; Song B; Ai H
    Biomaterials; 2014 Nov; 35(35):9495-507. PubMed ID: 25155545
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer-targeted MDR-1 siRNA delivery using self-cross-linked glycol chitosan nanoparticles to overcome drug resistance.
    Yhee JY; Song S; Lee SJ; Park SG; Kim KS; Kim MG; Son S; Koo H; Kwon IC; Jeong JH; Jeong SY; Kim SH; Kim K
    J Control Release; 2015 Jan; 198():1-9. PubMed ID: 25481438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model.
    Wang T; Gantier MP; Xiang D; Bean AG; Bruce M; Zhou SF; Khasraw M; Ward A; Wang L; Wei MQ; AlShamaileh H; Chen L; She X; Lin J; Kong L; Shigdar S; Duan W
    Theranostics; 2015; 5(12):1456-72. PubMed ID: 26681989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PEGylated hyaluronic acid-modified liposomal delivery system with anti-γ-glutamylcyclotransferase siRNA for drug-resistant MCF-7 breast cancer therapy.
    Ran R; Liu Y; Gao H; Kuang Q; Zhang Q; Tang J; Fu H; Zhang Z; He Q
    J Pharm Sci; 2015 Feb; 104(2):476-84. PubMed ID: 25256603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aptamer mediated siRNA delivery.
    Chu TC; Twu KY; Ellington AD; Levy M
    Nucleic Acids Res; 2006 Jun; 34(10):e73. PubMed ID: 16740739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate cancer cell death produced by the co-delivery of Bcl-xL shRNA and doxorubicin using an aptamer-conjugated polyplex.
    Kim E; Jung Y; Choi H; Yang J; Suh JS; Huh YM; Kim K; Haam S
    Biomaterials; 2010 Jun; 31(16):4592-9. PubMed ID: 20206379
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Advance in the study of targeting delivery system for siRNA mediated by aptamers].
    Wang XL; Wang QQ; Song HF
    Yao Xue Xue Bao; 2012 Jul; 47(7):850-5. PubMed ID: 22993847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of monensin liposomes on the cytotoxicity, apoptosis and expression of multidrug resistance genes in doxorubicin-resistant human breast tumour (MCF-7/dox) cell-line.
    Shaik MS; Chatterjee A; Singh M
    J Pharm Pharmacol; 2004 Jul; 56(7):899-907. PubMed ID: 15233869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery.
    Bao Y; Yin M; Hu X; Zhuang X; Sun Y; Guo Y; Tan S; Zhang Z
    J Control Release; 2016 Aug; 235():182-194. PubMed ID: 27264552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Target-specific delivery of doxorubicin to human glioblastoma cell line via ssDNA aptamer.
    Bayrac AT; Akca OE; Eyidogan FI; Oktem HA
    J Biosci; 2018 Mar; 43(1):97-104. PubMed ID: 29485118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ABCG2 aptamer selectively delivers doxorubicin to drug-resistant breast cancer cells.
    Hashemitabar S; Yazdian-Robati R; Hashemi M; Ramezani M; Abnous K; Kalalinia F
    J Biosci; 2019 Jun; 44(2):. PubMed ID: 31180052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemosensitization of doxorubicin in multidrug-resistant cells by unimolecular micelles via increased cellular accumulation and apoptosis.
    Wang M; Han M; Li Y; Jin Y; Gao JQ
    J Pharm Pharmacol; 2016 Mar; 68(3):333-41. PubMed ID: 26893058
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound.
    Bai M; Shen M; Teng Y; Sun Y; Li F; Zhang X; Xu Y; Duan Y; Du L
    Oncotarget; 2015 Dec; 6(41):43779-90. PubMed ID: 26575421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A polycation coated liposome as efficient siRNA carrier to overcome multidrug resistance.
    Xia Y; Wang X; Cheng H; Fang M; Ning P; Zhou Y; Chen W; Song H
    Colloids Surf B Biointerfaces; 2017 Nov; 159():427-436. PubMed ID: 28826111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sequential treatment of drug-resistant tumors with RGD-modified liposomes containing siRNA or doxorubicin.
    Jiang J; Yang SJ; Wang JC; Yang LJ; Xu ZZ; Yang T; Liu XY; Zhang Q
    Eur J Pharm Biopharm; 2010 Oct; 76(2):170-8. PubMed ID: 20600887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
    Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. siRNA Targeting of MDR1 Reverses Multidrug Resistance in a Nude Mouse Model of Doxorubicin-resistant Human Hepatocellular Carcinoma.
    Yang H; Ding R; Tong Z; Huang J; Shen L; Sun YU; Liao J; Yang Z; Hoffman RM; Wang C; Meng X
    Anticancer Res; 2016 Jun; 36(6):2675-82. PubMed ID: 27272776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.